1. Home
  2. ABVE vs AGEN Comparison

ABVE vs AGEN Comparison

Compare ABVE & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Above Food Ingredients Inc.

ABVE

Above Food Ingredients Inc.

N/A

Current Price

$1.12

Market Cap

133.6M

ML Signal

N/A

Logo Agenus Inc.

AGEN

Agenus Inc.

N/A

Current Price

$3.16

Market Cap

126.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABVE
AGEN
Founded
2019
1994
Country
Canada
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.6M
126.2M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ABVE
AGEN
Price
$1.12
$3.16
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
1.3M
372.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.37
Revenue
N/A
$42,877,086.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$68.25
P/E Ratio
N/A
$8.04
Revenue Growth
N/A
89.95
52 Week Low
$0.32
$1.38
52 Week High
$6.56
$7.34

Technical Indicators

Market Signals
Indicator
ABVE
AGEN
Relative Strength Index (RSI) 32.12 49.80
Support Level $0.90 $2.90
Resistance Level $2.08 $3.38
Average True Range (ATR) 0.12 0.18
MACD -0.02 0.01
Stochastic Oscillator 16.62 52.69

Price Performance

Historical Comparison
ABVE
AGEN

About ABVE Above Food Ingredients Inc.

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: